Q3 2025 Earnings Call Transcript February 5, 2025 Operator: Welcome to McKesson’s Third Quarter Fiscal 2025 Earnings ...

Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded. At this time, I'd like to turn the conference over to Rachel ...

With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating ...

McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...

McKesson posted adjusted earnings per share of $8.03 for the quarter ended December 31, 2024, missing the analyst consensus of $8.27. Revenue came in at $95.29 billion, up 18% YoY but below the $95.77 ...

MCK is set to acquire a controlling stake in PRISM Vision Holdings, aiming to expand its specialty care capabilities and strengthen its leadership in eye health solutions across the United States.

Welcome to McKesson's third quarter fiscal 2025 earnings conference call. Please be advised that today's conference is being ...

McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM ...

Luke Tuttle, who's held roles at industry giants including Experian and Klarna, will lead MoneyGram's product development and ...

McKesson Corporation has signed a definitive agreement to acquire an 80% stake in Prism Vision Holdings from Quad-C for approximately $850 million.

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...

After the purchase concludes, the firm intends to include PRISM Vision into its U.S. Pharmaceutical division subject to ...